LeonaBio Income Statement (2019-2026) | LONA

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
12.02M10.71M12.62M14.46M14.80M16.96M15.24M21.29M21.61M27.20M23.68M21.24M22.15M17.92M9.37M4.30M3.66M2.83M6.71M11.26M
Selling, General & Administrative (Quarter)
4.61M7.12M6.16M8.93M8.77M7.17M7.69M8.48M10.03M7.84M6.96M6.45M5.87M7.57M6.20M5.23M3.63M4.05M3.77M6.88M
Restructuring Costs (Quarter)
10.00M4.13M
Other Operating Expenses (Quarter)
1.60M-24.77M75.79M-7.66M-5.22M86.42M-17.25M
Operating Expenses (Quarter)
16.64M17.83M18.78M23.39M23.57M24.13M32.93M29.77M31.64M35.04M29.01M2.92M28.03M29.62M91.36M1.88M7.29M1.65M96.89M0.89M
Operating Income (Quarter)
-16.64M-17.83M-18.78M-23.39M-23.57M-24.13M-32.93M-29.77M-31.64M-35.04M-29.01M-27.69M-28.03M-29.62M-15.57M-9.54M-7.29M-6.87M-78.56M-17.21M
EBIT (Quarter)
-16.64M-17.83M-18.78M-23.39M-23.57M-24.13M-32.93M-29.77M-31.64M-35.04M-29.01M-27.69M-28.03M-29.62M-15.57M-9.54M-7.29M-6.87M-78.56M-17.21M
Non-operating items
Other Non Operating Income (Quarter)
0.07M0.07M0.10M0.17M0.49M0.98M1.56M1.79M2.04M2.07M1.73M1.35M1.17M0.88M0.56M0.39M0.33M0.26M0.26M0.59M
Non Operating Income (Quarter)
0.07M0.07M0.10M0.17M0.49M0.98M1.56M1.79M2.04M2.07M1.73M1.35M1.17M0.88M0.56M0.39M0.33M0.26M0.26M0.59M
Net income details
EBT (Quarter)
-16.64M-17.83M-18.78M-23.39M-23.57M-24.13M-32.93M-29.77M-31.64M-35.04M-29.01M-27.69M-28.03M-29.62M-15.57M-9.54M-7.29M-6.87M-78.56M-17.21M
Profit After Tax (Quarter)
-13.97M-15.67M-16.34M-20.98M-24.34M-20.19M-30.14M-27.82M-29.60M-32.97M-27.29M-26.34M-26.86M-28.74M-15.00M-9.14M-6.97M-6.61M-82.91M-32.90M
Income from Continuing Operations (Quarter)
-16.64M-17.83M-18.78M-23.39M-23.57M-24.13M-32.93M-29.77M-31.64M-35.04M-29.01M-27.69M-28.03M-29.62M-15.57M-9.54M-7.29M-6.87M-78.56M-17.21M
Consolidated Net Income (Quarter)
-16.64M-17.83M-18.78M-23.39M-23.57M-24.13M-32.93M-29.77M-31.64M-35.04M-29.01M-27.69M-28.03M-29.62M-15.57M-9.54M-7.29M-6.87M-78.56M-17.21M
Income towards Parent Company (Quarter)
-16.64M-17.83M-18.78M-23.39M-23.57M-24.13M-32.93M-29.77M-31.64M-35.04M-29.01M-27.69M-28.03M-29.62M-15.57M-9.54M-7.29M-6.87M-78.56M-17.21M
Net Income towards Common Stockholders (Quarter)
-16.64M-17.83M-18.78M-23.39M-23.57M-24.13M-32.93M-29.77M-31.64M-35.04M-29.01M-27.69M-28.03M-29.62M-15.57M-9.54M-7.29M-6.87M-78.56M-17.21M
Additional items
EPS (Basic) (Quarter)
-0.38-0.42-0.44-0.56-0.65-0.53-0.79-0.73-0.78-0.87-0.71-0.69-0.70-7.46-3.86-2.34-0.18-1.68-18.90-1.73
EPS (Weighted Average and Diluted) (Quarter)
-0.42-0.44-0.56-0.65-0.53-0.79-0.73-0.78-0.87-0.71-0.69-0.70-7.46-3.86-2.34-0.18-1.68-18.90-1.73
Shares Outstanding (Weighted Average) (Quarter)
36.50M37.31M36.92M37.59M37.67M37.82M37.73M37.92M37.96M37.99M38.02M38.32M38.38M3.85M3.85M3.90M39.09M3.94M5.50M19.03M
Shares Outstanding (Diluted Average) (Quarter)
37.31M36.92M37.59M37.63M37.69M37.73M37.92M38.00M38.05M38.02M38.32M38.38M3.85M3.85M3.90M39.09M3.94M4.28M19.03M
EBITDA (Quarter)
-13.96M-15.71M-16.73M-22.05M-24.80M-20.74M-29.62M-26.89M-29.51M-32.71M-26.96M-26.12M-26.76M-28.70M-15.01M-9.15M-6.96M-6.61M-82.89M-32.96M